Company Filing History:
1 out of 54 
1 out of 21 
1 out of 1,744 
Years Active: 2023
Title: William Lostal: Innovator in Synthetic Polynucleotides
Introduction
William Lostal is an esteemed inventor based in Savigny sur Orge, France. He is particularly recognized for his contribution to the field of biotechnology through his innovative work in synthetic polynucleotides. With a focus on addressing medical conditions related to FKRP protein deficiencies, Lostal’s work has the potential to impact many lives significantly.
Latest Patents
William Lostal holds a notable patent for synthetic polynucleotides encoding a human FKRP protein. The invention involves synthetic polynucleotides that contain specific mutations designed to prevent supplementary transcripts from being generated from frameshift start codons. This groundbreaking research is particularly relevant for treating pathologies associated with FKRP deficiencies or defects in α-dystroglycan (α-DG) glycosylation, such as Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I).
Career Highlights
Throughout his career, Lostal has been affiliated with prominent institutions such as Genethon and Université d'Evry Val d'Essonne. His work in these organizations has enabled him to develop pioneering solutions in the realm of genetic engineering and therapeutic innovations, thereby making significant contributions to the scientific community.
Collaborations
William Lostal has collaborated with several talented professionals, including Isabelle Richard and Evelyne Gicquel-Zouida. Together, they have worked on various projects, enhancing the scope of research in synthetic biology and genetic disorders. Their combined expertise has facilitated advancements in the understanding and treatment of diseases linked to FKRP deficiencies.
Conclusion
William Lostal is a prominent figure in the sphere of biotechnology, whose innovations pave the way for future therapies targeting genetic disorders. His patent on synthetic polynucleotides underscores the importance of ongoing research in developing efficient treatments for conditions like LGMD2I. As the field of genetic engineering evolves, inventors like Lostal continue to inspire advancements that hold promise for the health and well-being of many individuals.